Prognostic Significance of Survivin Expression in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Report from the International DLBCL Rituximab-CHOP Consortium Program
Year: 2015
Type: article
Authors: Zhiyu Liu, Zijun Y. Xu-Monette, Xin Cao, Carlo Visco, Alexander Tzankov, Santiago Montes-Moreno, Karen Dybkær, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W.L. Choi, J. Han van Krieken, Jooryung Huh, Weiyun Ai, Maurilio Ponzoni, Andrés J.M. Ferreri, John P. Farnen, Michael B. Møller, Jane N. Winter, Miguel A. Piris, L. Jeffrey Medeiros, Ken H. Young
Institutions: The University of Texas MD Anderson Cancer Center, Ospedale San Bortolo, University Hospital of Basel, Marqués de Valdecilla University Hospital, Aalborg University Hospital, Memorial Sloan Kettering Cancer Center, Cornell University, Weill Cornell Medicine, Houston Methodist, NewYork–Presbyterian Hospital, Columbia University Irving Medical Center, University of North Carolina at Chapel Hill, Cleveland Clinic, University of Hong Kong, Radboud University Medical Center, Asan Medical Center, University of Ulsan, University of California, San Francisco, IRCCS Ospedale San Raffaele, Gundersen Health System, Odense University Hospital, Northwestern University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2347074743